title: Different methods to calculate the inhibitory quotient of boosted single protease inhibitors and their association with virological response.
authors.forename: Alan
authors.initials: A
authors.lastname: Winston
authors.forename: Nimesh
authors.initials: N
authors.lastname: Patel
authors.forename: David
authors.initials: D
authors.lastname: Back
authors.forename: Saye
authors.initials: S
authors.lastname: Khoo
authors.forename: Steve
authors.initials: S
authors.lastname: Bulbeck
authors.forename: Sundhiya
authors.initials: S
authors.lastname: Mandalia
authors.forename: Anton L
authors.initials: AL
authors.lastname: Pozniak
authors.forename: Mark
authors.initials: M
authors.lastname: Nelson
authors.forename: Graeme
authors.initials: G
authors.lastname: Moyle
authors.forename: Brian
authors.initials: B
authors.lastname: Gazzard
authors.forename: Marta
authors.initials: M
authors.lastname: Boffito
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D006678:HIV / Q000187:drug effects / Q000302:isolation & purification / Q000502:physiology*; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D019562:Viral Load; D014779:Virus Replication
chemical_list: D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors